|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Non-controlled, non-affiliated investments (cost of $918,011 and $876,688 at June 30, 2026 and December 31, 2025, respectively) | |||||||||
| Cash and cash equivalents | |||||||||
| Deferred offering costs | |||||||||
| Cash | |||||||||
| Receivable for investments sold | |||||||||
| Deferred financing costs | |||||||||
| Interest, dividends and fee receivable | |||||||||
| Receivable from Adviser | |||||||||
| Prepaid expenses | |||||||||
| Prepaid expenses and other assets | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Due to affiliate | |||||||||
| Borrowings | |||||||||
| Distribution payable | |||||||||
| Interest payable | |||||||||
| Incentive fees payable | |||||||||
| Payable for investments purchased | |||||||||
| Loans sold under agreement to repurchase | |||||||||
| Investment income incentive fees payable | |||||||||
| Management fees payable | |||||||||
| Contributions received in advance | |||||||||
| Accrued capital gains incentive fees | |||||||||
| Accrued expenses and other liabilities | |||||||||
| Total liabilities | |||||||||
| Net Assets | |||||||||
| Common stock, $0.01 par value, 200,000,000 shares authorized, 27,234,435 and 24,058,078 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid in capital | |||||||||
| Distributable earnings (loss) | |||||||||
| Total net assets | |||||||||
| Total liabilities and net assets | |||||||||
| Net asset value per share (in dollars per share) | |||||||||
| Common stock, shares, outstanding (in shares) |
Loading...
